Authors
Latest:
Expanding the Role of the Pharmacist in the Wake of COVID-19Community pharmacists should consider leaning on their specialty pharmacist peers, where available, as we continue to navigate the new, more virtual normal and attempt to expand these types of services in the future.
Latest:
Cultural Competence Sets Pharmacy Professionals ApartTraining and knowledge about appropriate communication with individuals of diverse backgrounds improves adherence, outcomes.
Latest:
SGLT2 Inhibitors Are Underutilized for Inpatient Heart Failure TreatmentCardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.
Latest:
Good Samaritan Laws Aim to Encourage AssistanceBut in real-world situations, such as when a bystander administers naloxone, there are gray areas.
Latest:
Baby Steps to a Healthier You: Prioritizing Lifestyle Changes Over MedicationTake these 4 steps to help prevent health conditions and disease naturally.
Latest:
Updates on 2022 Changes to the American Diabetes Association Standards of CareMetformin has been the drug of choice for the treatment of diabetes since the 1950s, but new changes suggest the consideration of SGLT-2 inhibitors or GLT-1 agonists.
Latest:
Changing the Game: Pharmacy Students' Perspective on Naloxone OTC ApprovalTo eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.
Latest:
Lung Cancer Study Brings Pharmacists to the Forefront of Patient CarePharmacists have always been a vital member of the cancer care team, but the emergence of many new oral therapies is making their role in patient care a more prominent one.
Latest:
How Specialty Pharmacies Can Increase Access Through Patient FinancingIt’s essential that health care providers across the patient journey demystify the costs of treatment and provide solutions to overcome the financial barriers.
Latest:
Clinical Overview: Comparison of Anti-Amyloid Monoclonal Antibodies for Alzheimer DiseaseAducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.
Latest:
Looking Toward the Future of CDI ManagementClosing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Latest:
Breaking the Bank: Financial Toxicity in Cancer CareThe increasing economic burden of treatment may impact patient outcomes.
Latest:
Pharmacy Technicians as Non-Pharmacist Preceptors for a Sterile Compounding RotationRecognizing pharmacy technicians as non-pharmacist preceptors can provide an opportunity for professional development while encouraging technicians to practice at the top of their education and training activities.
Latest:
GOLD Guidelines Provide Recommendations on Managing COPDPivotal resource helps health care professionals diagnose, manage, and prevent this group of lung diseases.
Latest:
Clinical Overview: Treatment Recommendations for Pneumococcal DiseaseTreatment for community-acquired pneumococcal disease is dependent on patient-specific factors, whereas prevention with vaccinations is dependent on age and comorbidities.
Latest:
Equitable Representation in Triple-Negative Breast Cancer Clinical TrialsBlack women have higher rates of triple-negative breast cancer (TNBC) incidence and mortality than the general US population. Despite this, they are underrepresented in TNBC clinical trials.
Latest:
Considerations for RSV Prevention in Special Patient PopulationsOlder adults, patients with weakened immune systems, individuals living in long-term facilities, and those with underlying cardiopulmonary disease are at a higher risk of developing severe RSV infection outcomes.
Latest:
Point-of-Care Testing Offers New Opportunities for Pharmacy TechniciansBecoming experts in medical billing for point-of-care testing offers a new avenue for technicians to excel and show their value.
Latest:
Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial IntelligenceArtificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.
Latest:
Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple MyelomaIntegration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.
Latest:
Proper Use of Automation in Hazardous Drug Compounding PharmaciesAlthough robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.
Latest:
HOPA 2025: Matthew Lei, PharmD, BCOP, Shares Critical Themes and Hot Topic SessionsMatthew Lei, PharmD, BCOP, highlights the value of community, collaboration, and innovation at the HOPA Annual Conference.
Latest:
Specialty Drug Commercialization Process and ConsiderationsAs specialty drugs move through clinical trials and preparations for commercialization begin, significant attention is warranted to this process considering the massive investments that would have been already made in the product up to this point.
Latest:
Use of Lutetium Lu-177 Vipivotide Tetraxetan to Treat Metastatic Castration-Resistant Prostate CancerThe FDA-approved, targeted radiopharmaceutical agent can contribute to a patient’s cumulative radiation exposure.
Latest:
Only a Phone Call Away: The Development of a Transplant Telepharmacy Consult Service For a Large Medical SystemTransplant patients must adhere to lifelong regimens and those caring for them must consider their regimen as the patients intersect with different parts of the health care system.
Latest:
Making “Rheum” for Biosimilars: Overcoming ReluctanceDespite the proven efficacy of biosimilars, both patients and health care providers often have some reluctance when switching from an originator drug to a biosimilar.
Latest:
Can Flexibility Fix Pharmacies? The Case for Contingent WorkersIt’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.
Latest:
Patient Navigation in the Specialty Pharmacy SpaceLack of access to novel therapies, especially within the cancer space, initiated the road to patient navigation.
Latest:
What’s Ahead in the Adalimumab Biosimilar Pipeline in DermatologyFDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
